(Q37325443)

19 August 2017

1 reference

title

The curious case of the tumour virus: 50 years of Burkitt's lymphoma (English)

1 reference

19 August 2017

0 references

0 references

0 references

2

Martin J Allday

1 reference

19 August 2017

David A Thorley-Lawson

series ordinal

1

1 reference

PubMed ID

19008891

19 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Nature Reviews Microbiology

19 August 2017

1 reference

19 August 2017

6

1 reference

19 August 2017

913-924

1 reference

19 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro2015

19 August 2017

0 references

cites work

A sarcoma involving the jaws in African children

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

CANCER IN AN AFRICAN COMMUNITY, 1897--1956. AN ANALYSIS OF THE RECORDS OF MENGO HOSPITAL, KAMPALA, UGANDA. I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Marker band in one chromosome 14 from Burkitt lymphomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus-associated epithelial and mesenchymal neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Early events in Epstein-Barr virus infection provide a model for B cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus: exploiting the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

A novel form of Epstein-Barr virus latency in normal B cells in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The role of EBV in post-transplant malignancies: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Molecular biology of Burkitt's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Classification and biological nature of established human hematopoietic cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

EBV persistence in memory B cells in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Influence of EBV on the peripheral blood memory B cell compartment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

AID is required for germinal center-derived lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Germinal centres: role in B-cell physiology and malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

A role for AID in chromosome translocations between c-myc and the IgH variable region.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Burkitt lymphoma in the mouse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The c-Myc target gene network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Global mapping of c-Myc binding sites and target gene networks in human B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Widespread microRNA repression by Myc contributes to tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

c-Myc-regulated microRNAs modulate E2F1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

B cell activation and the establishment of Epstein-Barr virus latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

B cell receptor signal strength determines B cell fate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Regulation of lymphocyte development by Notch signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Default repression and Notch signaling: Hairless acts as an adaptor to recruit the corepressors Groucho and dCtBP to Suppressor of Hairless

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Transcriptional regulation by C-terminal binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Chromatin profiling of Epstein-Barr virus latency control region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus latent membrane protein 2A and autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Endemic Burkitt's lymphoma: a polymicrobial disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Identification of a polyclonal B-cell activator in Plasmodium falciparum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Deregulation of the cell cycle by the Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Chikungunya fever as a risk factor for endemic Burkitt's lymphoma in Malawi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Non-Hodgkin's lymphoma in childhood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Mechanisms of chromosomal translocations in B cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Lymphoid malignancies: the dark side of B-cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Molecular diagnosis of Burkitt's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Transcriptional analysis of the B cell germinal center reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Signatures of the immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

31 March 2020

Oncogenes and cell death

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Role of genetic and epigenetic changes in Burkitt lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The role of BH3-only proteins in the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

The great MYC escape in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

inferred from DOI database lookup

7 January 2021

based on heuristic

Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

inferred from DOI database lookup

7 January 2021

based on heuristic

Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRMICRO2015

1 reference

19 August 2017

1 reference

PubMed ID

19008891